Prevalence of neutralizing autoantibodies against type I interferon in dengue patients
Journal of Human Immunity · 02.11.2026 · 2 (6)
DOI: 10.70962/jhi.20260072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 01.09.2026. Verfasst von Mengtian Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation of Key-Area Research and Development Program of Guangdong Province, National Natural Science Foundation of China, Science and Technology Project of Guangzhou.
Abstract (Originalsprache)
The presence of neutralizing autoantibodies (NAbs) against type I IFN (IFN-I) has been associated with severe complications arising from various viral infections. However, the prevalence of IFN-I NAbs in dengue virus (DENV) infection remains unclear. Here, we enrolled 216 hospitalized dengue patients in 2024, including 7 individuals with dengue shock syndrome (DSS) and 42 individuals with dengue hemorrhagic fever (DHF). Utilizing a sensitive luciferase reporter assay, IFN-I NAbs were detected in 7 patients (14.3% of DSS/DHF cases), and their neutralizing ability was further validated in DENV-infected cells. Notably, all NAb-positive patients exhibited plasma leakage tendency and cardiac injury and were significantly older than the overall cohort (75.34 vs. 50.75, P = 0.010). IFN-I NAbs were correlated with clinical parameters of myocardial injury and plasma leakage, with increased odds ratio (OR) for cardiac injury (OR = 22.8, P = 0.003) and hypoproteinemia (OR = 53.5, P = 0.001). These findings suggest that IFN-I NAbs may contribute to severe clinical manifestations of dengue, warranting validation in larger cohorts.
Autor:innen und Institutionen
- Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Guangzhou Key Laboratory of Clinical Pathogen Research for Infectious Diseases, Guangzhou, China.
- Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
ORCID-Profile: Mengtian Yang, Yixin Liao, Xiaorong Yang, Jiaqi Fan, Min Liao, Yongchang Wu, Huiqin Yang, Jian Wang, Wei Zhang, Feng Li, Haisheng Yu, Yun Ling
Förderung
- Foundation of Key-Area Research and Development Program of Guangdong Province
- National Natural Science Foundation of China
- Science and Technology Project of Guangzhou
- Key Discipline Program on Public Health System Construction of Shanghai
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- Shanghai Eastern Talent Plan
- Three-Year Action Plan
- Shanghai Public Health Center
Zitieren
APA
Yang, M., Liao, Y., Yang, X., Fan, J., Liao, M., Wu, Y., Yang, H., Wang, J., Zhang, W., Li, F., Yu, H., & Ling, Y. (2026). Prevalence of neutralizing autoantibodies against type I interferon in dengue patients. Journal of Human Immunity, 2(6). https://doi.org/10.70962/jhi.20260072
Vancouver
Yang M, Liao Y, Yang X, Fan J, Liao M, Wu Y, et al. Prevalence of neutralizing autoantibodies against type I interferon in dengue patients. Journal of Human Immunity. 2026;2(6). doi:10.70962/jhi.20260072
BibTeX
@article{Yang2026,
author = {Yang, Mengtian and Liao, Yixin and Yang, Xiaorong and Fan, Jiaqi and Liao, Min and Wu, Yongchang and Yang, Huiqin and Wang, Jian and Zhang, Wei and Li, Feng and Yu, Haisheng and Ling, Yun},
title = {Prevalence of neutralizing autoantibodies against type I interferon in dengue patients},
journal = {Journal of Human Immunity},
year = {2026},
volume = {2},
number = {6},
doi = {10.70962/jhi.20260072}
}
EUVIMED